Brief: Ryvu Therapeutics Signs Two Service Deals For River-52 And River-81 Studies
Aug 4 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS TWO DEALS WITH FORTREA FOR SERVICES ON RIVER-52, AND
RIVER-81 CLINICAL STUDIES
* TOTAL DEAL FOR RIVER-52 VALUE AMOUNTS TO ABOUT EUR 10.9
MILLION
* TOTAL DEAL FOR RIVER-81 VALUE AMOUNTS UP TO ABOUT EUR 11.5
MILLION
* SERVICES UNDER DEALS WILL COMPRISE OF OPERATIONAL
EXECUTION OF
CLINICAL STUDIES, SUCH AS MANAGEMENT OF CLINICAL PROJECT,
MEDICAL AND SECURITY MONITORING
Source text for Eikon: ID:nEM2LL46Ta
Further company coverage: RVU.WA FTRE.O
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys